Literature DB >> 31187884

The response of five intestinal cell lines to anoxic conditions in vitro.

Hanne Vissenaekens1, Charlotte Grootaert1, Andreja Rajkovic1, Tom Van De Wiele2, Marta Calatayud2.   

Abstract

BACKGROUND INFORMATION: In vivo oxygen levels in tissues range from 1% to 15%, while mechanistic cell culture studies employ an atmospheric oxygen level of 21% to grow cells. These oxygen concentrations are therefore not representative for conditions where the cell response is dependent on oxygen partial pressure. In pathological situation, such as (colon) cancer or chronic inflammation, tissue oxygenation is severely affected, and even under physiological conditions a steep oxygen gradient is present in the large intestine, where epithelial cells co-exist with microbial species, resulting in almost anoxia at the midpoint of the lumen. In these situations, a better characterisation of the essential cellular behaviour under hypoxia or anoxia is required.
RESULTS: We have characterised the cellular response of commonly used cell cultures for the study of intestinal epithelial processes and colon cancer development (Caco-2, HT-29, SW480, HCT 116 and LoVo) under conventional normoxic conditions (21% O2 ) and in an anoxic (<0.1% O2 ) environment generated in an anaerobic chamber. In general, anoxic conditions led to lower levels of oxidative stress, a reduction in reduced glutathione/oxidised glutathione (GSH/GSSG) ratio, the shift of the redox status to oxidised glutathione levels, reduced cell proliferation, decreased barrier function and higher glycolysis rates at the expense of oxidative respiration.
CONCLUSIONS: Continuous exposure to anoxic conditions, such as occurring at the host-microbe interface in the intestine, may create an adaptive metabolic cellular response of the cells. SIGNIFICANCE: Considering adequate oxygen levels is essential for creating more physiologically relevant models for the study of host-microbe interactions and colon cancer development.
© 2019 Société Française des Microscopies and Société de Biologie Cellulaire de France. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Anoxia; Metabolism; Mitochondria; Oxidative stress; intestine

Mesh:

Substances:

Year:  2019        PMID: 31187884     DOI: 10.1111/boc.201800076

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  5 in total

1.  Growth of various obligate and facultative anaerobic intestinal bacteria in cell culture medium under aerobic and anaerobic culture conditions.

Authors:  Toshifumi Ohkusa; Shigeo Koido; Sankichi Horiuchi; Shin Kan; Zensho Ito; Yuriko Nishikawa; Nobuhiro Sato
Journal:  Biosci Microbiota Food Health       Date:  2022-02-24

2.  The stimulatory effect of fusobacteria on dendritic cells under aerobic or anaerobic conditions.

Authors:  Shigeo Koido; Sankichi Horiuchi; Shin Kan; Tsuuse Bito; Zensho Ito; Kan Uchiyama; Masayuki Saruta; Nobuhiro Sato; Toshifumi Ohkusa
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

3.  Patient Derived Colonoids as Drug Testing Platforms-Critical Importance of Oxygen Concentration.

Authors:  Helene Kolstad Skovdahl; Shreya Gopalakrishnan; Tarjei Dahl Svendsen; Atle van Beelen Granlund; Ingunn Bakke; Zekarias G Ginbot; Silje Thorsvik; Arnar Flatberg; Bjørnar Sporsheim; Jenny Ostrop; Tom Eirik Mollnes; Arne Kristian Sandvik; Torunn Bruland
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

Review 4.  Beyond Heat Stress: Intestinal Integrity Disruption and Mechanism-Based Intervention Strategies.

Authors:  Puqiao Lian; Saskia Braber; Johan Garssen; Harry J Wichers; Gert Folkerts; Johanna Fink-Gremmels; Soheil Varasteh
Journal:  Nutrients       Date:  2020-03-11       Impact factor: 5.717

5.  Bioenergetic Status of the Intestinal and Hepatic Cells after Short Term Exposure to Fumonisin B1 and Aflatoxin B1.

Authors:  Xiangrong Chen; Mohamed F Abdallah; Charlotte Grootaert; Andreja Rajkovic
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.